drugset / Trial / NCT00257712

SMART: Somatotrophics, Memory, and Aging Research Trial

NCT00257712

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the SMART study was to better understand whether the body's own production of growth hormone (GH) would improve memory and problem solving ability, or cognitive function. The study was a double blind, placebo-controlled study of the cognitive effects of growth hormone releasing hormone (GHRH) in healthy older men and women and in those with mild cognitive impairment (MCI).

Timeline

Start
2006-02
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tesamorelin Peptide 1 mg Subcutaneous